Cargando…
Author Correction: Post-treatment with PT302, a long-acting Exendin-4 sustained release formulation, reduces dopaminergic neurodegeneration in a 6-Hydroxydopamine rat model of Parkinson’s disease
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6135809/ https://www.ncbi.nlm.nih.gov/pubmed/30209317 http://dx.doi.org/10.1038/s41598-018-31455-w |
| _version_ | 1783354878943297536 |
|---|---|
| author | Chen, Shuchun Yu, Seong-Jin Li, Yazhou Lecca, Daniela Glotfelty, Elliot Kim, Hee Kyung Choi, Ho-Il Hoffer, Barry J. Greig, Nigel H. Kim, Dong Seok Wang, Yun |
| author_facet | Chen, Shuchun Yu, Seong-Jin Li, Yazhou Lecca, Daniela Glotfelty, Elliot Kim, Hee Kyung Choi, Ho-Il Hoffer, Barry J. Greig, Nigel H. Kim, Dong Seok Wang, Yun |
| author_sort | Chen, Shuchun |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6135809 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2018 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-61358092018-09-15 Author Correction: Post-treatment with PT302, a long-acting Exendin-4 sustained release formulation, reduces dopaminergic neurodegeneration in a 6-Hydroxydopamine rat model of Parkinson’s disease Chen, Shuchun Yu, Seong-Jin Li, Yazhou Lecca, Daniela Glotfelty, Elliot Kim, Hee Kyung Choi, Ho-Il Hoffer, Barry J. Greig, Nigel H. Kim, Dong Seok Wang, Yun Sci Rep Author Correction Nature Publishing Group UK 2018-09-12 /pmc/articles/PMC6135809/ /pubmed/30209317 http://dx.doi.org/10.1038/s41598-018-31455-w Text en © The Author(s) 2018 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
| spellingShingle | Author Correction Chen, Shuchun Yu, Seong-Jin Li, Yazhou Lecca, Daniela Glotfelty, Elliot Kim, Hee Kyung Choi, Ho-Il Hoffer, Barry J. Greig, Nigel H. Kim, Dong Seok Wang, Yun Author Correction: Post-treatment with PT302, a long-acting Exendin-4 sustained release formulation, reduces dopaminergic neurodegeneration in a 6-Hydroxydopamine rat model of Parkinson’s disease |
| title | Author Correction: Post-treatment with PT302, a long-acting Exendin-4 sustained release formulation, reduces dopaminergic neurodegeneration in a 6-Hydroxydopamine rat model of Parkinson’s disease |
| title_full | Author Correction: Post-treatment with PT302, a long-acting Exendin-4 sustained release formulation, reduces dopaminergic neurodegeneration in a 6-Hydroxydopamine rat model of Parkinson’s disease |
| title_fullStr | Author Correction: Post-treatment with PT302, a long-acting Exendin-4 sustained release formulation, reduces dopaminergic neurodegeneration in a 6-Hydroxydopamine rat model of Parkinson’s disease |
| title_full_unstemmed | Author Correction: Post-treatment with PT302, a long-acting Exendin-4 sustained release formulation, reduces dopaminergic neurodegeneration in a 6-Hydroxydopamine rat model of Parkinson’s disease |
| title_short | Author Correction: Post-treatment with PT302, a long-acting Exendin-4 sustained release formulation, reduces dopaminergic neurodegeneration in a 6-Hydroxydopamine rat model of Parkinson’s disease |
| title_sort | author correction: post-treatment with pt302, a long-acting exendin-4 sustained release formulation, reduces dopaminergic neurodegeneration in a 6-hydroxydopamine rat model of parkinson’s disease |
| topic | Author Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6135809/ https://www.ncbi.nlm.nih.gov/pubmed/30209317 http://dx.doi.org/10.1038/s41598-018-31455-w |
| work_keys_str_mv | AT chenshuchun authorcorrectionposttreatmentwithpt302alongactingexendin4sustainedreleaseformulationreducesdopaminergicneurodegenerationina6hydroxydopamineratmodelofparkinsonsdisease AT yuseongjin authorcorrectionposttreatmentwithpt302alongactingexendin4sustainedreleaseformulationreducesdopaminergicneurodegenerationina6hydroxydopamineratmodelofparkinsonsdisease AT liyazhou authorcorrectionposttreatmentwithpt302alongactingexendin4sustainedreleaseformulationreducesdopaminergicneurodegenerationina6hydroxydopamineratmodelofparkinsonsdisease AT leccadaniela authorcorrectionposttreatmentwithpt302alongactingexendin4sustainedreleaseformulationreducesdopaminergicneurodegenerationina6hydroxydopamineratmodelofparkinsonsdisease AT glotfeltyelliot authorcorrectionposttreatmentwithpt302alongactingexendin4sustainedreleaseformulationreducesdopaminergicneurodegenerationina6hydroxydopamineratmodelofparkinsonsdisease AT kimheekyung authorcorrectionposttreatmentwithpt302alongactingexendin4sustainedreleaseformulationreducesdopaminergicneurodegenerationina6hydroxydopamineratmodelofparkinsonsdisease AT choihoil authorcorrectionposttreatmentwithpt302alongactingexendin4sustainedreleaseformulationreducesdopaminergicneurodegenerationina6hydroxydopamineratmodelofparkinsonsdisease AT hofferbarryj authorcorrectionposttreatmentwithpt302alongactingexendin4sustainedreleaseformulationreducesdopaminergicneurodegenerationina6hydroxydopamineratmodelofparkinsonsdisease AT greignigelh authorcorrectionposttreatmentwithpt302alongactingexendin4sustainedreleaseformulationreducesdopaminergicneurodegenerationina6hydroxydopamineratmodelofparkinsonsdisease AT kimdongseok authorcorrectionposttreatmentwithpt302alongactingexendin4sustainedreleaseformulationreducesdopaminergicneurodegenerationina6hydroxydopamineratmodelofparkinsonsdisease AT wangyun authorcorrectionposttreatmentwithpt302alongactingexendin4sustainedreleaseformulationreducesdopaminergicneurodegenerationina6hydroxydopamineratmodelofparkinsonsdisease |